✦ LIBER ✦

Survival in prostate cancer patients

✍ Scribed by Jesco Pfitzenmaier; Sascha Pahernik; Stephan Buse; Axel Haferkamp; Nenad Djakovic; Markus Hohenfellner

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 288 KB
Volume: 27
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-009-0414-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gleason score and pretreatment prostate-

Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer

✍ William D. Figg; Michael E. Franks; David Venzon; Paul Duray; Michael C. Cox; W. 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 230 KB

Effects of skeletal morbidities on longi

Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer

✍ Venita DePuy; Kevin J. Anstrom; Liana D. Castel; Kevin A. Schulman; Kevin P. Wei 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 115 KB

The Phoenix definition of biochemical fa

The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer

✍ Matthew C. Abramowitz; Tiaynu Li; Mark K. Buyyounouski; Eric Ross; Robert G. Uzz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## Abstract ## BACKGROUND. The American Society for Therapeutic Radiology and Oncology (ASTRO) definition of biochemical failure (BF) incorporates backdating, resulting in an artificial flattening of Kaplan‐Meier curves and overly favorable estimates when follow‐up is short. The nadir + 2 ng/mL (N

Significant associations of prostate can

Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy

✍ Bo-Ying Bao; Jiunn-Bey Pao; Chun-Nung Huang; Yeong-Shiau Pu; Ta-Yuan Chang; Yu-H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB

## Abstract Androgen‐deprivation therapy (ADT) is the most common therapy for advanced prostate cancer, but the prognosis significantly differs among individuals. In this study, we evaluated recently identified 19 prostate cancer susceptibility variants as prognostic predictors for the survival aft

Cancer-specific survival and predictors

Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy

✍ Fernando P. Secin; Fernando J. Bianco Jr.; Andrew J. Vickers; Victor Reuter; Tho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the long‐term biochemical recurrence (BCR) and cancer‐specific survival (CSS) rates for men with seminal vesicle invasion (SVI) and to identify risk factors for freedom from BCR and CSS in patients who received treatme

Elevated plasma tissue inhibitor of meta

Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients

✍ William K. Oh; Roberto Vargas; Susanna Jacobus; Kim Leitzel; Meredith M. Regan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

## Abstract ## BACKGROUND. Tissue inhibitor of metalloproteinase‐1 (TIMP‐1) has paradoxical multifunctional roles in tumorigenesis: inhibition of the catalytic activity of matrix metalloproteinases and apoptosis as well as promotion of angiogenesis and tumor growth. Elevated TIMP‐1 levels have bee